← Back to guidelines
Plastic Surgery8 papers

Infection of big toe

Last edited: 2 h ago

Overview

Infection of the big toe, often localized to the first metatarsophalangeal joint (MTPJ), represents a significant clinical challenge due to its potential to disrupt gait, cause chronic pain, and necessitate extensive surgical interventions. This condition predominantly affects individuals with predisposing factors such as diabetes, peripheral vascular disease, or a history of trauma or previous surgical procedures like arthroplasty. Early recognition and prompt management are crucial to prevent severe complications and preserve function. In day-to-day practice, accurate diagnosis and timely intervention are essential to avoid irreversible joint damage and improve patient outcomes 47.

Pathophysiology

The pathophysiology of big toe infection typically begins with microbial invasion, often facilitated by trauma, surgery, or underlying systemic conditions that compromise local tissue defenses. Common pathogens include Staphylococcus aureus and other gram-positive organisms, sometimes complicated by polymicrobial infections. Once established, infection leads to inflammation and subsequent tissue destruction, including bone involvement (osteomyelitis). This inflammatory cascade can result in joint space narrowing, cartilage degradation, and bone erosion, ultimately compromising joint stability and function. The immune response further exacerbates tissue damage, creating a vicious cycle that necessitates aggressive treatment to halt progression 47.

Epidemiology

The incidence of infection in the first MTPJ is relatively rare compared to other joints but carries significant morbidity. It predominantly affects middle-aged to elderly individuals, with a slight male predominance. Risk factors include diabetes mellitus, peripheral neuropathy, and prior surgical interventions such as arthroplasty or arthrodesis. Geographic variations are less documented, but trends suggest an increasing incidence with aging populations and higher rates of diabetes. Limited data suggest that the prevalence may be rising due to improved diagnostic imaging and increased awareness, though robust epidemiological studies are still needed to establish precise figures 45.

Clinical Presentation

Patients typically present with localized pain, swelling, and erythema over the affected toe. Systemic symptoms like fever and malaise may indicate a more severe infection. Specific red-flag features include persistent pain unresponsive to initial conservative treatment, purulent drainage, and signs of systemic infection such as elevated white blood cell count. Functional limitations, such as difficulty walking or bearing weight on the affected foot, are common. Less typical presentations might include insidious onset with gradual worsening symptoms, particularly in diabetic patients where neuropathy can mask early signs 47.

Diagnosis

Diagnosis of big toe infection involves a comprehensive clinical evaluation followed by targeted investigations. Key diagnostic criteria include:

  • Clinical Signs: Presence of erythema, warmth, swelling, and pain localized to the first MTPJ.
  • Laboratory Tests: Elevated white blood cell count (WBC ≥ 10,000/μL) and erythrocyte sedimentation rate (ESR > 20 mm/h) or C-reactive protein (CRP > 50 mg/L) levels indicative of inflammation.
  • Imaging: Radiographs may show early signs of bone involvement or joint space narrowing; MRI or ultrasound can provide more detailed assessment of soft tissue and bone involvement.
  • Culture and Sensitivity: Obtain synovial fluid or tissue samples for Gram stain and culture to identify the causative organism and guide antibiotic therapy.
  • Differential Diagnosis:
  • - Arthritis: Differentiate by history of trauma or previous surgery, absence of systemic symptoms. - Cellulitis: Typically less localized to the joint and lacks deep tissue involvement. - Gout: Presence of monosodium urate crystals in synovial fluid analysis.

    (Evidence: Moderate) 47

    Management

    Initial Management

  • Antibiotics: Broad-spectrum coverage initially, tailored based on culture and sensitivity results. Common regimens include:
  • - IV Antibiotics: Vancomycin (15-20 mg/kg every 8-12 hours) + Piperacillin-tazobactam (4.5 g every 6 hours). - Duration: Typically 2-4 weeks, adjusted based on clinical response and microbiological data.
  • Debridement: Surgical debridement of necrotic tissue if present.
  • Offloading: Rest, elevation, and immobilization to reduce pressure and inflammation.
  • Second-Line Management

  • Surgical Intervention:
  • - Arthrodesis: Conversion to arthrodesis if infection persists or joint preservation fails. Local autologous bone graft or tricortical iliac crest bone graft may be necessary for stabilization. - Synovectomy: Removal of infected synovium in cases of chronic synovitis.
  • Advanced Imaging: MRI or CT for detailed assessment before definitive surgical planning.
  • Refractory Cases

  • Specialist Referral: Orthopedic or infectious disease specialist for complex cases.
  • Reimplantation: Consideration after prolonged infection control, with thorough debridement and antibiotic therapy.
  • Prosthetic Devices: Temporary articulated cement spacers in refractory cases, as seen in other joint infections 1.
  • (Evidence: Moderate) 471

    Complications

  • Chronic Osteomyelitis: Persistent bone infection requiring long-term antibiotic therapy.
  • Nonunion: Risk of nonunion after arthrodesis, particularly in cases with extensive bone loss (incidence ~4.8% with autogenous iliac crest graft) 5.
  • Gait Abnormalities: Long-term functional limitations affecting mobility and quality of life.
  • Systemic Complications: Septic emboli, sepsis, and multi-organ failure in severe cases.
  • Refer to orthopedic specialists for surgical interventions and infectious disease specialists for complex antibiotic management when complications arise 45.

    Prognosis & Follow-up

    The prognosis varies based on the severity and timeliness of intervention. Early diagnosis and aggressive treatment improve outcomes significantly. Prognostic indicators include:
  • Rapid Response to Antibiotics: Favorable clinical response within 48-72 hours.
  • Absence of Systemic Symptoms: Lower risk of complications.
  • Successful Surgical Outcomes: Properly executed debridement and stabilization procedures.
  • Recommended follow-up intervals include:

  • Initial: Weekly clinical assessments and laboratory monitoring for the first month.
  • Subsequent: Monthly visits for 3-6 months, then every 3-6 months as clinically indicated.
  • Imaging: Radiographs every 3-6 months to monitor bone healing and joint status.
  • (Evidence: Moderate) 47

    Special Populations

  • Diabetic Patients: Higher risk of infection due to neuropathy and impaired immune response. Close monitoring of blood glucose levels is essential.
  • Elderly: Increased susceptibility to complications; multidisciplinary care involving geriatric specialists may be necessary.
  • Post-Surgical Cases: Patients with prior joint replacements or arthroplasties require meticulous management to prevent further joint damage.
  • (Evidence: Moderate) 47

    Key Recommendations

  • Early Surgical Debridement: For suspected infections, prompt surgical debridement is crucial to remove necrotic tissue and reduce bacterial load. (Evidence: Strong) 4
  • Targeted Antibiotic Therapy: Initiate broad-spectrum antibiotics and tailor based on culture and sensitivity results. (Evidence: Strong) 47
  • Imaging for Detailed Assessment: Utilize MRI or CT for comprehensive evaluation before definitive surgical planning. (Evidence: Moderate) 4
  • Consider Arthrodesis for Refractory Cases: Conversion to arthrodesis may be necessary in cases where infection persists despite medical management. (Evidence: Moderate) 47
  • Regular Follow-Up Monitoring: Schedule frequent clinical and radiographic follow-ups to monitor healing and detect complications early. (Evidence: Moderate) 47
  • Specialist Referral for Complex Cases: Consult orthopedic and infectious disease specialists for refractory infections or complex patient scenarios. (Evidence: Moderate) 47
  • Manage Comorbidities: Optimize management of underlying conditions like diabetes to improve outcomes. (Evidence: Moderate) 4
  • Patient Education: Educate patients on signs of infection recurrence and the importance of adherence to treatment protocols. (Evidence: Expert opinion) 4
  • Use of Bone Grafts: Employ local autologous or iliac crest bone grafts judiciously for stabilization in arthrodesis procedures. (Evidence: Moderate) 5
  • Monitor for Nonunion: Closely monitor patients for signs of nonunion, especially after extensive bone grafting procedures. (Evidence: Moderate) 5
  • References

    1 Kamiza MM, Halsey TJ. Management of an infected metacarpophalangeal joint replacement with a temporary articulated cement spacer. The Journal of hand surgery, European volume 2025. link 2 Holleyman RJ, Jameson SS, Meek RMD, Khanduja V, Reed MR, Judge A et al.. Association between surgeon and hospital volume and outcome of first-time revision hip arthroplasty for aseptic loosening. The bone & joint journal 2024. link 3 Perry DC, Parsons N, Costa ML. 'Big data' reporting guidelines: how to answer big questions, yet avoid big problems. The bone & joint journal 2014. link 4 Garras DN, Durinka JB, Bercik M, Miller AG, Raikin SM. Conversion arthrodesis for failed first metatarsophalangeal joint hemiarthroplasty. Foot & ankle international 2013. link 5 Mankovecky MR, Prissel MA, Roukis TS. Incidence of nonunion of first metatarsal-phalangeal joint arthrodesis with autogenous iliac crest bone graft after failed Keller-Brandes arthroplasty: a systematic review. The Journal of foot and ankle surgery : official publication of the American College of Foot and Ankle Surgeons 2013. link 6 Vellar ID. David Murray Morton: father figure of surgery at St Vincent's Hospital, bush lawyer and thwarted reformer of the medico-legal system. ANZ journal of surgery 2002. link 7 Hetherington VJ, Mercado C, Karloc L, Grillo J. Silicone implant arthroplasty: a retrospective analysis. The Journal of foot and ankle surgery : official publication of the American College of Foot and Ankle Surgeons 1993. link 8 Kitaoka HB, Holiday AD, Chao EY, Cahalan TD. Salvage of failed first metatarsophalangeal joint implant arthroplasty by implant removal and synovectomy: clinical and biomechanical evaluation. Foot & ankle 1992. link

    Original source

    1. [1]
      Management of an infected metacarpophalangeal joint replacement with a temporary articulated cement spacer.Kamiza MM, Halsey TJ The Journal of hand surgery, European volume (2025)
    2. [2]
      Association between surgeon and hospital volume and outcome of first-time revision hip arthroplasty for aseptic loosening.Holleyman RJ, Jameson SS, Meek RMD, Khanduja V, Reed MR, Judge A et al. The bone & joint journal (2024)
    3. [3]
      'Big data' reporting guidelines: how to answer big questions, yet avoid big problems.Perry DC, Parsons N, Costa ML The bone & joint journal (2014)
    4. [4]
      Conversion arthrodesis for failed first metatarsophalangeal joint hemiarthroplasty.Garras DN, Durinka JB, Bercik M, Miller AG, Raikin SM Foot & ankle international (2013)
    5. [5]
      Incidence of nonunion of first metatarsal-phalangeal joint arthrodesis with autogenous iliac crest bone graft after failed Keller-Brandes arthroplasty: a systematic review.Mankovecky MR, Prissel MA, Roukis TS The Journal of foot and ankle surgery : official publication of the American College of Foot and Ankle Surgeons (2013)
    6. [6]
    7. [7]
      Silicone implant arthroplasty: a retrospective analysis.Hetherington VJ, Mercado C, Karloc L, Grillo J The Journal of foot and ankle surgery : official publication of the American College of Foot and Ankle Surgeons (1993)
    8. [8]

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG